Patents by Inventor Edmund Kelly
Edmund Kelly has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Patent number: 7202273Abstract: Therapeutic methods of treatment, compositions and foodstuffs are described which contain isoflavone compounds described by general formula (1), in which Z is H, R1 is H, or RACO where RA is C1-10alkyl or an amino acid, R2 is H, OH, or ORB where RB is an amino acid, or CORA where RA is as previously defined, W is H, A is H or OH, and B is selected from (a), (b), (c), or W is H, and A and B taken together form a six-membered ring selected from (d), or W, A and B taken with the groups with which they are associated comprise (e), or W and A taken together with the groups with which they are associated comprise (f) and B is (g) wherein R3 is H, CORA where RA is as previously defined, CO2Rc where RC is C1-10alkyl, or CORB where RB is as previously defined, R4 is H, CORD where RD is H, OH, C1-10alkyl or an amino acid, CO2RC where RC is as previously defined, CORE where RE is H, C1-10alkyl or an amino acid, COOH, CORC where RC is as previously defined, or CONHRE where RE is as previously defined, R5 is H, CORC whereType: GrantFiled: June 21, 2002Date of Patent: April 10, 2007Assignee: Novogen Research Pty LtdInventors: Graham Edmund Kelly, George Eustace Joannou
-
Patent number: 7045155Abstract: Compositions enriched with natural phyto-oestrogens or analogues thereof selected from Genistein, Daidzein, Formononetin and Biochanin A. These may be used as food additives, tablets or capsules for promoting health in cases of cancer, pre-menstrual syndrome, menopause or hypercholesterolaemia.Type: GrantFiled: October 21, 2002Date of Patent: May 16, 2006Assignee: Novogen Research Pty Ltd.Inventor: Graham Edmund Kelly
-
Publication number: 20060095591Abstract: A cluster of computer processor nodes, a communications network joining the processor nodes for communicating commands and data, and means for providing a globally accurate clock to all of the processor nodes for timing operations utilizing the communications network.Type: ApplicationFiled: September 24, 2004Publication date: May 4, 2006Inventor: Edmund Kelly
-
Publication number: 20060085555Abstract: A cluster of computers including a plurality of processing nodes, a command network connecting to each of the processor nodes, and circuitry for addressing each of the processor nodes on the command network based on a position of the processor node on the command network.Type: ApplicationFiled: September 24, 2004Publication date: April 20, 2006Inventor: Edmund Kelly
-
Publication number: 20060069811Abstract: Apparatus for providing a cluster processing system including a plurality of processing nodes, each node having a processor and associated local memory, each node being capable of responding to software commands to execute operations on data and to store the results of the operations locally, one of the processing nodes further comprising devices for furnishing external inputs to and receiving outputs from the cluster processing system; a first network fixedly joining the processing nodes for communication of data and software among the nodes; and a second network joining the processing nodes for control of the nodes.Type: ApplicationFiled: August 27, 2004Publication date: March 30, 2006Inventor: Edmund Kelly
-
Publication number: 20060047943Abstract: Apparatus and a method for booting each of a plurality of computer processor nodes in a cluster system to run the same cluster operating system.Type: ApplicationFiled: August 27, 2004Publication date: March 2, 2006Inventor: Edmund Kelly
-
Patent number: 6987098Abstract: Compositions enriched with natural phyto-oestrogens or analogues thereof selected from Genistein, Daidzein, Formononetin and Biochanin A. These may be used as food additives, tablets or capsules for promoting health in cases of cancer, pre-menstrual syndrome, menopause or hypercholesterolaemia.Type: GrantFiled: July 2, 2003Date of Patent: January 17, 2006Assignee: Novogen Research Pty. Ltd.Inventor: Graham Edmund Kelly
-
Publication number: 20040170713Abstract: This invention relates to natural products containing phyto-oestrogens, or phyto-oestrogen analogues, which have various beneficial physiological effects in man, and which have a variety of uses, such as to promote good health and as a dietary additive, for example. The invention describes a method of improving the health of a human by administering to the human a health supplementing amount of a phyto-oestrogen selected from genistein, daidzein formononentin and/or biochanin A. A health supplement comprising a health supplementary amount of a phyto-oestrogen selected from genisten daidzein formononentin and/or biochanin A, is also described. Preferably, the supplement also comprises at least one dietary suitable excipient, diluent, carrier or food, and may be in the form of a tablet or capsule, for example. Ideally, the phyto-oestrogen is extracted from red clover or from soya, although any source rich in isoflavones may also be used.Type: ApplicationFiled: March 11, 2004Publication date: September 2, 2004Applicant: Novogen Research Pty Ltd.Inventor: Graham Edmund Kelly
-
Publication number: 20040152761Abstract: A compound of the general formula (I) or (II) wherein X is O, NR4 or S and R1-R8 are as defined in the specification.Type: ApplicationFiled: March 8, 2004Publication date: August 5, 2004Inventors: Andrew Heaton, Graham Edmund Kelly, Naresh Kumar
-
Publication number: 20040147551Abstract: Isoflavone compounds are described and recommended as therapeutic agents. Exemplified and preferred compounds are (a). Indications show compounds have good competitive binding to estrogen receptors. This is exemplified.Type: ApplicationFiled: November 7, 2003Publication date: July 29, 2004Applicant: Novogen Research Pty Ltd.Inventors: Andrew Heaton, Naresh Kumar, Graham Edmund Kelly, Alan Husband
-
Publication number: 20040106561Abstract: This invention relates to natural products containing phyto-oestrogens, or phyto-oestrogen analogues, which have various beneficial physiological effects in man, and which have a variety of uses, such as to promote good health and as a dietary additive, for example. The invention describes a method of improving the health of a human by administering to the human a health supplementing amount of a phyto-oestrogen selected from genistein, daidzein formononentin and/or biochanin A. A health supplement comprising a health supplementary amount of a phyto-oestrogen selected from genisten daidzein formononentin and/or biochanin A, is also described. Preferably, the supplement also comprises at least one dietary suitable excipient, diluent, carrier or food, and may be in the form of a tablet or capsule, for example. Ideally, the phyto-oestrogen is extracted from red clover or from soya, although any source rich in isoflavones may also be used.Type: ApplicationFiled: July 2, 2003Publication date: June 3, 2004Applicant: Novogen Research Pty. Ltd.Inventor: Graham Edmund Kelly
-
Publication number: 20040082539Abstract: A process for the production of &bgr;-(1,3)(1,6) glucan from a glucan containing cellular source is described, together with compositions and uses/methods of treatment involving glucan.Type: ApplicationFiled: April 22, 2003Publication date: April 29, 2004Applicant: Novogen Research Party, Ltd.Inventor: Graham Edmund Kelly
-
Publication number: 20040072765Abstract: Compositions comprising formononetin and/or one or more isoflavones selected from biochanin, genistein and daidzein, in a therapeutically effective ratio of formononetin to said isoflavones of 15:1 to 2:1, optionally in association with one or more carriers, excipients, auxiliaries and/or diluents are described. Also described are methods of treatment involving such compositions including the prevention and/or treatment of cardiovascular disease, the beneficial alteration of blood lipoprotein levels, or a reduction in the risk of vascular disease, or a reduction in the risk of coronary heart disease, or a reduction in the risk of arteriosclerosis, or in the beneficial alteration or maintenance of bone density such as in the prevention or treatment of osteoporosis, and/or in the prevention and/or treatment of bone fracture.Type: ApplicationFiled: June 18, 2003Publication date: April 15, 2004Applicant: Novogen Research Pty Ltd.Inventors: Graham Edmund Kelly, Alan James Husband
-
Publication number: 20040048812Abstract: This invention relates to natural products containing phyto-oestrogens, or phyto-oestrogen analogues, which have various beneficial physiological effects in man, and which have a variety of uses, such as to promote good health and as a dietary additive, for example. The invention describes a method of improving the health of a human by administering to the human a health supplementing amount of a phyto-oestrogen selected from genistein, daidzein formononentin and/or biochanin A. A health supplement comprising a health supplementary amount of a phyto-oestrogen selected from genisten daidzein formononentin and/or biochanin A, is also described. Preferably, the supplement also comprises at least one dietary suitable excipient, diluent, carrier or food, and may be in the form of a tablet or capsule, for example. Ideally, the phyto-oestrogen is extracted from red clover or from soya, although any source rich in isoflavones may also be used.Type: ApplicationFiled: July 2, 2003Publication date: March 11, 2004Applicant: Novogen Research Pty. Ltd.Inventor: Graham Edmund Kelly
-
Patent number: 6668287Abstract: Apparatus and a method for generating an interrupt when a direct memory access by an I/O device is desired, suspending the operation of the microprocessor in response to the interrupt, placing state of the morph host to a last known correct state in response to the interrupt, determining the memory operation commanded by the I/O device, and utilizing the microprocessor to execute the memory operation commanded by the I/O device.Type: GrantFiled: December 15, 1999Date of Patent: December 23, 2003Assignee: Transmeta CorporationInventors: Patrick Boyle, David Keppel, Alex Klaiber, Edmund Kelly
-
Publication number: 20030219499Abstract: A method for the treatment, prophylaxis, amelioration or prevention of disorders associated with abnormally high activity of steroidal estrogens, which includes administering to a human subject a composition comprising an isoflavone-containing extract of clover or chick peas, said extract comprising primarily biochanin, or a ratio of biochanin to one or more of the isoflavones from the group formononetin, daidzein and genistein in the range of from about 2:1 to about 5:1, optionally in association with one or more pharmaceutically acceptable carriers, excipients, auxiliaries and/or diluents is described. Also described are compositions and uses comprising the isoflavone containing extracts.Type: ApplicationFiled: June 12, 2003Publication date: November 27, 2003Applicant: Novogen Research Pty LtdInventors: Graham Edmund Kelly, Alan James Husband
-
Patent number: 6649648Abstract: Therapeutic methods of treatment, compositions and foodstuffs are described which contain isoflavone compounds described by general formula (I), in which Z is H, R1 is H, or RACO where RA is C1-10alkyl or an amino acid, R2 is H, OH, or ORB where RB is an amino acid, or CORA where RA is as previously defined, W is H, A is H or OH, and B is selected from (a), (b), (c), or W is H, and A and B taken together form a six-membered ring selected from (d), or W, A and B taken with the groups with which they are associated comprise (e), or W and A taken together with the groups with which they are associated comprise (f) and B is (g) wherein R3 is H, CORA where RA is as previously defined, CO2RC where RC is C1-10alkyl, or CORB where RB is as previously defined, R4 is H, CORD where RD is H, OH, C1-10alkyl or an amino acid, CO2RC where RC is as previously defined, CORE where RE is H, C1-10alkyl or an amino acid, COOH, CORC where RC is as previously defined, or CONHRE where RE is as previously defined, R5 is H, CO2RC wherType: GrantFiled: August 5, 1999Date of Patent: November 18, 2003Assignee: Novogen Research Pty LimitedInventors: Graham Edmund Kelly, George Eustace Joannou
-
Patent number: 6642212Abstract: Compositions enriched with natural phyto-oestrogens or analogues thereof selected from Genistein, Diadzein, Formononectin and Biochanin A. These compositions may be used as food additives, tablets or capsules for promoting health in cases of cancer, pre-menstrual syndrome, menopause or hypercholesterolaemia.Type: GrantFiled: October 19, 1999Date of Patent: November 4, 2003Assignee: Novogen Research Pty. Ltd.Inventor: Graham Edmund Kelly
-
Publication number: 20030157225Abstract: Food products and pharmaceutical preparations containing one or more isoflavones are described. In particular, the invention relates to highly purified, crystalline isoflavones having an agreeable taste, texture and mouth-feel when formulated in food products and pharmaceutical preparations, and methods for the production of the highly purified, crystalline isoflavones.Type: ApplicationFiled: November 7, 2002Publication date: August 21, 2003Inventors: Alan James Husband, Graham Edmund Kelly
-
Patent number: 6599536Abstract: A method for the treatment, prophylaxis, amelioration or prevention of disorders associated with abnormally high activity of steroidal estrogens, which includes administering to a human subject a composition comprising an isoflavone-containing extract of clover or chick peas, said extract comprising primarily biochanin, or a ratio of biochanin to one or more of the isoflavones from the group formononetin, daidzein and genistein in the range of from about 2:1 to about 5:1, optionally in association with one or more pharmaceutically acceptable carriers, excipients, auxiliaries and/or diluents is described. Also described are compositions and uses comprising the isoflavone containing extracts.Type: GrantFiled: December 5, 2000Date of Patent: July 29, 2003Assignee: Novogen Research Pty LtdInventors: Graham Edmund Kelly, Alan James Husband